During the past decade, Frauenarzt-Zentrum Zehlendorf an der Teltower Eiche conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Frauenarzt-Zentrum Zehlendorf an der Teltower Eiche" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Fondazione Michelangelo" with 2 trials sponsored, "Genentech, Inc." with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Puma Biotechnology, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Frauenarzt-Zentrum Zehlendorf an der Teltower Eiche" #1 collaborator was "Breast International Group" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Frauenarzt-Zentrum Zehlendorf an der Teltower Eiche" are "Breast Cancer" (4 trials), "Breast Neoplasms" (1 trials), "Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer" (1 trials), "Invasive Ductal Breast Carcinoma" (1 trials) and "Neoplasm Metastasis" (1 trials). Many other conditions were trialed in "Frauenarzt-Zentrum Zehlendorf an der Teltower Eiche" in a lesser frequency.

Most popular intervention types in "Frauenarzt-Zentrum Zehlendorf an der Teltower Eiche" are "Drug" (8 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (4 trials), "Docetaxel" (3 trials), "Pertuzumab" (3 trials), "Trastuzumab" (3 trials) and "5-Fluorouracil" (2 trials). Other intervention names were less common.

The vast majority of trials in "Frauenarzt-Zentrum Zehlendorf an der Teltower Eiche" are 5 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Frauenarzt-Zentrum Zehlendorf an der Teltower Eiche". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Frauenarzt-Zentrum Zehlendorf an der Teltower Eiche, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Frauenarzt-Zentrum Zehlendorf an der Teltower Eiche, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".